Literature DB >> 2623725

Sexual decision-making and AIDS: why condom promotion among vulnerable women is likely to fail.

D Worth1.   

Abstract

This article examines the reasons for resistance to condom use among high-risk women (primarily intravenous drug users and/or the sexual partners of intravenous drug users) in two New York City AIDS prevention programs. The data collected indicate that a lack of economic, social, cultural, sexual, and technological options combine to lead vulnerable women to concentrate on addressing the more immediate risks in their lives: poverty, homelessness, and the frequent disruption of socioeconomic support systems. Resistance to condom use was also found to be related to its negative associations (promiscuity, for example). The process by which decisions are made about using condoms (and other contraceptives) is related to a complex mixture of social, economic, and cultural influences that promote the role of motherhood for a woman, even when she knows that she might already be infected with human immunodeficiency virus (HIV). The implications of these findings have far-reaching effects, as the socioeconomic context of these women's lives, as well as imbalances in power in the relationships between the women and their male partners, are replicated in many communities where AIDS is already present.

Entities:  

Mesh:

Year:  1989        PMID: 2623725

Source DB:  PubMed          Journal:  Stud Fam Plann        ISSN: 0039-3665


  71 in total

1.  Racial/ethnic disparities in the HIV and substance abuse epidemics: communities responding to the need.

Authors:  H Amaro; A Raj; R R Vega; T W Mangione; L N Perez
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

2.  Future directions for violence against women and reproductive health: science, prevention, and action.

Authors:  J C Campbell; K E Moracco; L E Saltzman
Journal:  Matern Child Health J       Date:  2000-06

3.  Correlates of HIV risk-taking behaviors among African-American college students: the effect of HIV knowledge, motivation, and behavioral skills.

Authors:  M Bazargan; E M Kelly; J A Stein; B A Husaini; S H Bazargan
Journal:  J Natl Med Assoc       Date:  2000-08       Impact factor: 1.798

Review 4.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

5.  The effects of an abusive primary partner on the condom use and sexual negotiation practices of African-American women.

Authors:  G M Wingood; R J DiClemente
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

6.  Incidence of violence against HIV-infected and uninfected women: findings from the HIV Epidemiology Research (HER) study.

Authors:  Leslie Gruskin; Stephen J Gange; David Celentano; Paula Schuman; Janet S Moore; Sally Zierler; David Vlahov
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

7.  Gender, violence and HIV: women's survival in the streets.

Authors:  María Esther Epele
Journal:  Cult Med Psychiatry       Date:  2002-03

8.  HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania.

Authors:  Suzanne Maman; Jessie K Mbwambo; Nora M Hogan; Gad P Kilonzo; Jacquelyn C Campbell; Ellen Weiss; Michael D Sweat
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

9.  Concerns about partner infidelity are a barrier to adoption of HIV-prevention strategies among young South African couples.

Authors:  Lisa Parker; Audrey Pettifor; Suzanne Maman; Jabu Sibeko; Catherine MacPhail
Journal:  Cult Health Sex       Date:  2014-05-12

10.  Motivations for PrEP-Related Interpersonal Communication Among Women Who Inject Drugs: A Qualitative Egocentric Network Study.

Authors:  Marisa Felsher; Emmanuel Koku; Stephen Lankenau; Kathleen Brady; Scarlett Bellamy; Alexis M Roth
Journal:  Qual Health Res       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.